Biochemical analyses show that in normal brains tau has a phosphate content ranging from 2 to 3 moles per mole of tau, while the phosphate content increases to 5–9 moles per mole of tau in the brains of AD patients [271]. Here, MAPT is linked to Alzheimer disease.